For decades, the FDA made it nearly impossible to know which factories were manufacturing your generic medications.

Revenue increased by 6% to $115.8 million for the three months ended September 30, 2025, compared to $109.6 million for the same period in 2024. Revenue for the first nine months of September 2025 ...

Objectives To explore the levels of health-related functioning during pregnancy and postpartum and its association with non-severe maternal morbidities. Design An observational longitudinal study.